# Scientists Engineer Magic Mushroom Compound That Treats Depression Without Hallucinations

*2026-03-09 03:01 UTC · Science · 1 min read*

> A new psilocin derivative called 4e treats depression in mice without causing hallucinations, potentially revolutionizing psychedelic therapy.

Researchers have created a modified version of psilocin — the active compound in magic mushrooms — that retains its antidepressant properties while dramatically reducing psychedelic side effects. The compound, dubbed 4e, is a fluorinated derivative that releases psilocin gradually into the brain, staying below the threshold that triggers hallucinations. In mouse studies, animals treated with 4e exhibited significantly fewer head twitches, a key marker of psychedelic activity, compared to those given standard psilocybin.

The study, led by Sara De Martin, Andrea Mattarei, and Paolo Manfredi and published in the Journal of Medicinal Chemistry, showed that 4e crossed the blood-brain barrier effectively and activated serotonin receptors at levels comparable to psilocin. Mattarei said the findings suggest that "psychedelic effects and serotonergic activity may be dissociated," opening the door to treatments for depression, anxiety, substance use disorders, and neurodegenerative diseases like Alzheimer's — without mind-altering trips.

The research is still preclinical, and further studies including human clinical trials will be needed to confirm that the non-hallucinogenic effect carries over from mice to people.

## Sources

- [sciencedaily.com](https://www.sciencedaily.com/releases/2026/03/260307213232.htm)
- [neurosciencenews.com](https://neurosciencenews.com/non-hallucinogenic-psilocybin-30258/)

---
TechTools News · https://techtools.cz/tools/news/article/666-scientists-engineer-magic-mushroom-compound-that-treats-depression-without
Česká verze: https://techtools.cz/tools/news/clanek/678-vedci-vytvorili-slouceninu-z-halucinogennich-hub-ktera-leci-depresi-bez
